Company / AR per Share
ENANTA PHARMACEUTICALS INC AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.32
FY2025
5-year range
$0.32 / $1.17
FY2021-FY2025
Trend
+2.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share returned to growth in FY2025 after 6 years of decline, reaching $0.32.
Based on SEC 10-K filings.
0.32 in FY2025 with a 5-year CAGR of -22.9%.
Declined from $0.41 to $0.32 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- -31.4%
- 5-Year CAGR
- -22.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, ar per share increased 2.9% year-over-year.
- Peak ar per share was recorded in FY2018.
- Lowest ar per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.32 | +2.9% |
| FY2024 | $0.32 | -23.8% |
| FY2023 | $0.41 | -58.7% |
| FY2022 | $1.00 | -14.5% |
| FY2021 | $1.17 | -1.5% |
| FY2020 | $1.19 | -54.9% |
| FY2019 | $2.65 | -24.7% |
| FY2018 | $3.51 | +530.4% |
| FY2017 | $0.56 | -18.7% |
| FY2016 | $0.69 | -16.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026